Articaine HCl Formula Structure (85dfc4ff E676 4dac 9dd8 63c15af9842c 01)
Ultacan
Product Images NDC 52120-200
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ultacan (NDC 52120-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hansamed, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Epinephrine Bitartrate Formula Structure (85dfc4ff E676 4dac 9dd8 63c15af9842c 02)
Principal Display Panel (1:200,000)
This is a description of Ultacan', a sterile injection used for infiltration and nerve block anesthesia in intraoral submucosal areas. It contains articaine hydrochloride 4% and epinephrine 1:200,000 injection, USP, along with sodium metabisulfite. The distributed by HANSAmed Inc. and comes in 50x 1.7mL single-use cartridges. The insert includes warnings related to sodium metabisulfite. Contact information for HANSAmed Inc. is provided.*
Principal Display Panel (1:100,000)
This is a description of a medical product with the NDC number 52120-100-05 called Ultacan® 1D. It is a sterile injection for infiltration and nerve block anesthesia containing 4% articaine hydrochloride and 1:100,000 epinephrine. The injection is meant for intraoral submucosal use and is distributed by HANSAmed Inc. The package includes 50 single-use cartridges, each with a volume of 1.7 mL. The product contains sodium metabisulfite which is discussed in the warnings section of the insert.*
Principal Display Panels (1:200,000 Side)
Ultacan is a dental anesthetic injection containing Articaine hydrochloride 4% and epinephrine 1:200,000. It is manufactured by Sanofi-Aventis Deutschland GmbH and sold by HANSAmed Inc. The injection should not be administered intravenously, and it is meant for professional use only in dentistry. Ultacan should not be used if the color appears pinkish or darker, or if it contains a precipitate. It should be stored in a protected area from light and should not be frozen. Directions for use are provided in the package.*
Principal Display Panels (1:100,000 Side)
Ultacan® is a registered trademark of Sanofi-Aventis Deutschland GmbH that contains 4% articaine hydrochloride and epinephrine 1:100,000 injection, USP. It is for professional use only in the practice of dentistry and must not be injected intravenously. Each milliliter contains sodium chloride, sodium metabisulfite, water for injection, and sodium hydroxide. The product is made by Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt, Germany, for HANSAmed Inc. The directions for use must be consulted before use. The product must be kept in the carton until ready to use and protected from light. If the color is pinkish or darker than slightly yellow or contains a precipitate, do not use. It should also not be frozen.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
